| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |